Literature DB >> 18931988

[New perspectives in the laboratory diagnosis of dementia].

M Bibl1, J Wiltfang.   

Abstract

Over the past 10 years, the status of laboratory analysis in dementia has increasingly changed from its use for exclusion diagnoses for secondary causes of dementias to determining positive diagnoses of neurodegenerative dementias. This especially applies to the cerebrospinal fluid diagnosis of Alzheimer's disease (AD). Just a few years ago, a lumbar puncture was advised only with sufficiently founded clinical suspicion and with higher priority for the exclusion of inflammatory causes of cognitive dementias. In contrast, pathologically changed biomarkers in the cerebrospinal fluid have already been indexed as supportive attributes of the diagnosis in the 2007 amended research criteria of AD. The lumbar puncture is therefore increasingly becoming part of the clinical routine diagnosis of demential processes and has, to some extent, far-reaching consequences. In this article, we discuss some of the important aspects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931988     DOI: 10.1007/s00115-008-2498-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

Review 1.  Therapeutic approaches to Alzheimer's disease.

Authors:  Hans-Wolfgang Klafki; Matthias Staufenbiel; Johannes Kornhuber; Jens Wiltfang
Journal:  Brain       Date:  2006-10-03       Impact factor: 13.501

Review 2.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

Review 3.  Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics.

Authors:  Mirko Bibl; Jens Wiltfang
Journal:  Expert Rev Proteomics       Date:  2008-04       Impact factor: 3.940

Review 4.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

Review 5.  Circulating biomarkers of cognitive decline and dementia.

Authors:  Vincenzo Solfrizzi; Alessia D'Introno; Anna Maria Colacicco; Cristiano Capurso; Orlando Todarello; Vincenza Pellicani; Sabrina A Capurso; Giuseppe Pietrarossa; Vito Santamato; Antonio Capurso; Francesco Panza
Journal:  Clin Chim Acta       Date:  2005-09-01       Impact factor: 3.786

6.  Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

Authors:  Marieke van Oijen; Albert Hofman; Holly D Soares; Peter J Koudstaal; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

7.  Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

Authors:  M Bibl; B Mollenhauer; P Lewczuk; H Esselmann; S Wolf; C Trenkwalder; M Otto; G Stiens; E Rüther; J Kornhuber; J Wiltfang
Journal:  Mol Psychiatry       Date:  2007-03-06       Impact factor: 15.992

8.  Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

Authors:  Alessia Maddalena; Andreas Papassotiropoulos; Britta Müller-Tillmanns; Hans H Jung; Thomas Hegi; Roger M Nitsch; Christoph Hock
Journal:  Arch Neurol       Date:  2003-09

Review 9.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

10.  CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  Mirko Bibl; Brit Mollenhauer; Hermann Esselmann; Piotr Lewczuk; Hans-Wolfgang Klafki; Katrin Sparbier; Alexandr Smirnov; Lukas Cepek; Claudia Trenkwalder; Eckart Rüther; Johannes Kornhuber; Markus Otto; Jens Wiltfang
Journal:  Brain       Date:  2006-04-06       Impact factor: 13.501

View more
  1 in total

1.  [Mild cognitive impairment in old age. Diagnostics and prognostic significance].

Authors:  F M Reischies; F Wertenauer
Journal:  Nervenarzt       Date:  2011-11       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.